Table 3. Demographic characteristics of patients in PHIS-assembled cohort compared to the National Cancer Institute’s SEER program.
PHIS-assembled (n = 1,395*) | SEER 2004–2013 (n = 1,477) | P-value | |||
---|---|---|---|---|---|
Number | % | Number | % | ||
Age category | |||||
<1 | 2 | 0.14 | 4 | 0.27 | <0.001 |
≥1 and <5 | 182 | 13.1 | 170 | 11.51 | |
≥5 and <10 | 374 | 26.8 | 301 | 20.38 | |
≥10 and <15 | 434 | 31.1 | 402 | 27.22 | |
≥15 and <20 | 403 | 28.9 | 600 | 40.62 | |
Gender | |||||
Male | 1,058 | 75.8 | 1007 | 68.18 | <0.001 |
Female | 337 | 24.2 | 470 | 31.82 | |
Race | |||||
White | 951 | 68.2 | 1131 | 76.57 | 0.03 |
Black | 131 | 9.4 | 203 | 13.74 | |
Other** | 294 | 21.1 | 130 | 8.8 | |
Unknown** | 19 | 1.4 | 13 | 0.9 |
*14 subjects aged 20–21 in the PHIS-assembled cohort are excluded from all comparisons, as the NCI SEER program does not include this specific age range.
**Other/unknown categories were excluded from this comparison